Please try another search
Chongqing Lummy Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. The company provides antibacterial, antifungal, antiviral agent, acid-base balance nutritional, liver auxiliary, Chinese patent, base large infusion drugs; American ginseng; and drugs for the treatment of tumors, as well as digestive, immune, blood, nervous, cardiovascular, and endocrinology systems. It also offers sodium bicarbonate injection. The company was founded in 1999 and is headquartered in Chongqing, China.
Name | Age | Since | Title |
---|---|---|---|
Xue Feng Leng | 52 | 2016 | Deputy General Manager and Vice Chairman |
Yuan Yuan | 42 | 2017 | Chairman of Supervisory Board |
Geng Chen | 51 | 2020 | Independent Director |
Xujiang Chen | 51 | 2020 | Independent Director |
Jiansheng Liang | 42 | 2021 | Chairman |
Song Lin | 51 | 2022 | Deputy GM & Director |
Hai Run Wang | 36 | 2023 | Director |
Changbi Li | 52 | 2020 | Independent Director |
Weiyan Tang | 39 | 2020 | Director |
Mingyue Tan | 31 | 2021 | Supervisor |
Rihua Ou | 48 | 2020 | Director |
Huichuan Xu | 46 | 2014 | Employee Supervisor |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review